Nutrien Ltd. (NYSE:NTR) Stock Position Decreased by Keene & Associates Inc.

Keene & Associates Inc. decreased its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 39.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 35,464 shares of the company’s stock after selling 22,980 shares during the quarter. Keene & Associates Inc.’s holdings in Nutrien were worth $1,587,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of NTR. Uncommon Cents Investing LLC raised its position in shares of Nutrien by 2.1% during the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company’s stock worth $517,000 after purchasing an additional 235 shares during the period. Rhumbline Advisers increased its position in Nutrien by 3.5% in the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company’s stock worth $331,000 after buying an additional 247 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in Nutrien by 6.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company’s stock worth $207,000 after buying an additional 263 shares during the period. Meixler Investment Management Ltd. lifted its stake in Nutrien by 4.2% in the third quarter. Meixler Investment Management Ltd. now owns 7,159 shares of the company’s stock valued at $344,000 after buying an additional 288 shares during the last quarter. Finally, Atria Investments Inc boosted its holdings in shares of Nutrien by 2.0% during the third quarter. Atria Investments Inc now owns 14,636 shares of the company’s stock valued at $703,000 after acquiring an additional 290 shares during the period. Institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

NTR stock opened at $51.66 on Wednesday. The firm has a 50-day moving average of $49.13 and a two-hundred day moving average of $48.13. The firm has a market capitalization of $25.37 billion, a PE ratio of 34.67, a P/E/G ratio of 1.14 and a beta of 0.81. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a one year low of $43.69 and a one year high of $60.87.

Analysts Set New Price Targets

NTR has been the topic of a number of analyst reports. Piper Sandler increased their price objective on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Scotiabank lifted their price target on Nutrien from $59.00 to $60.00 and gave the company a “sector outperform” rating in a report on Monday, February 10th. TD Securities reduced their price objective on Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research report on Tuesday, November 12th. Oppenheimer started coverage on Nutrien in a research report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price on the stock. Finally, JPMorgan Chase & Co. upgraded Nutrien from an “underweight” rating to a “neutral” rating and boosted their price target for the stock from $40.00 to $50.00 in a research report on Monday, January 13th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $59.00.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.